MX2008002065A - Derivados de pirazola como agentes terapeuticos. - Google Patents
Derivados de pirazola como agentes terapeuticos.Info
- Publication number
- MX2008002065A MX2008002065A MX2008002065A MX2008002065A MX2008002065A MX 2008002065 A MX2008002065 A MX 2008002065A MX 2008002065 A MX2008002065 A MX 2008002065A MX 2008002065 A MX2008002065 A MX 2008002065A MX 2008002065 A MX2008002065 A MX 2008002065A
- Authority
- MX
- Mexico
- Prior art keywords
- therapeutic agents
- pyrazole derivatives
- diarylpyrazole
- carboxamides
- psychiatric
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 150000003217 pyrazoles Chemical class 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0516661.6A GB0516661D0 (en) | 2005-08-13 | 2005-08-13 | Therapeutic agents |
| PCT/GB2006/002990 WO2007020388A1 (en) | 2005-08-13 | 2006-08-09 | Pyrazole derivatives as therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2008002065A true MX2008002065A (es) | 2008-04-16 |
Family
ID=35098275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2008002065A MX2008002065A (es) | 2005-08-13 | 2006-08-09 | Derivados de pirazola como agentes terapeuticos. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1915364A1 (zh) |
| JP (1) | JP2009504717A (zh) |
| KR (1) | KR20080039939A (zh) |
| CN (1) | CN101282963A (zh) |
| AR (1) | AR055368A1 (zh) |
| AU (1) | AU2006281300A1 (zh) |
| BR (1) | BRPI0614626A2 (zh) |
| CA (1) | CA2619228A1 (zh) |
| EC (1) | ECSP088250A (zh) |
| GB (1) | GB0516661D0 (zh) |
| IL (1) | IL188759A0 (zh) |
| MX (1) | MX2008002065A (zh) |
| NO (1) | NO20080372L (zh) |
| RU (1) | RU2008108179A (zh) |
| TW (1) | TW200728300A (zh) |
| UY (1) | UY29741A1 (zh) |
| WO (1) | WO2007020388A1 (zh) |
| ZA (1) | ZA200800698B (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008015032A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
| DE102008015033A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| DE102008062878A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte Furancarboxamide und ihre Verwendung |
| DE102008062863A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung |
| DE102009036604A1 (de) | 2009-07-30 | 2011-02-03 | Aicuris Gmbh & Co. Kg | Substituierte Bis-Arylpyrazolamide mit terminaler primärer Amidfunktionalisierung und ihre Verwendung |
| DE102011055815A1 (de) | 2011-11-29 | 2013-05-29 | Aicuris Gmbh & Co. Kg | Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung |
| DE102012016908A1 (de) | 2012-08-17 | 2014-02-20 | Aicuris Gmbh & Co. Kg | Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung |
| CN105061227A (zh) * | 2015-07-27 | 2015-11-18 | 广东先强药业有限公司 | 一种环保的盐酸利托君生产方法 |
| WO2020123855A1 (en) | 2018-12-12 | 2020-06-18 | University Of Washington | Inhibitor compounds for male contraception |
| KR20250176791A (ko) | 2024-06-13 | 2025-12-22 | 인천대학교 산학협력단 | 피라졸 유도체를 유효성분으로 포함하는 항노화 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL377778A1 (pl) * | 2002-12-02 | 2006-02-20 | Astellas Pharma Inc. | Pochodne pirazolu |
| US7247628B2 (en) * | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| KR20060131906A (ko) * | 2004-02-20 | 2006-12-20 | 아스트라제네카 아베 | Ｃｂ1 조절제로서 유용한 3-치환 1,5-디페닐피라졸 유도체 |
-
2005
- 2005-08-13 GB GBGB0516661.6A patent/GB0516661D0/en not_active Ceased
-
2006
- 2006-08-01 TW TW095128062A patent/TW200728300A/zh unknown
- 2006-08-08 AR ARP060103449A patent/AR055368A1/es unknown
- 2006-08-09 WO PCT/GB2006/002990 patent/WO2007020388A1/en not_active Ceased
- 2006-08-09 BR BRPI0614626-0A patent/BRPI0614626A2/pt not_active Application Discontinuation
- 2006-08-09 KR KR1020087004570A patent/KR20080039939A/ko not_active Withdrawn
- 2006-08-09 JP JP2008526536A patent/JP2009504717A/ja active Pending
- 2006-08-09 CN CNA2006800374501A patent/CN101282963A/zh active Pending
- 2006-08-09 AU AU2006281300A patent/AU2006281300A1/en not_active Abandoned
- 2006-08-09 CA CA002619228A patent/CA2619228A1/en not_active Abandoned
- 2006-08-09 MX MX2008002065A patent/MX2008002065A/es not_active Application Discontinuation
- 2006-08-09 EP EP06779114A patent/EP1915364A1/en not_active Withdrawn
- 2006-08-09 RU RU2008108179/04A patent/RU2008108179A/ru not_active Application Discontinuation
- 2006-08-11 UY UY29741A patent/UY29741A1/es not_active Application Discontinuation
-
2008
- 2008-01-14 IL IL188759A patent/IL188759A0/en unknown
- 2008-01-21 NO NO20080372A patent/NO20080372L/no not_active Application Discontinuation
- 2008-01-23 ZA ZA200800698A patent/ZA200800698B/xx unknown
- 2008-03-07 EC EC2008008250A patent/ECSP088250A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200728300A (en) | 2007-08-01 |
| IL188759A0 (en) | 2008-08-07 |
| CN101282963A (zh) | 2008-10-08 |
| RU2008108179A (ru) | 2009-09-20 |
| JP2009504717A (ja) | 2009-02-05 |
| WO2007020388A1 (en) | 2007-02-22 |
| AR055368A1 (es) | 2007-08-22 |
| CA2619228A1 (en) | 2007-02-22 |
| BRPI0614626A2 (pt) | 2012-12-04 |
| NO20080372L (no) | 2008-04-16 |
| EP1915364A1 (en) | 2008-04-30 |
| ZA200800698B (en) | 2009-01-28 |
| UY29741A1 (es) | 2007-03-30 |
| GB0516661D0 (en) | 2005-09-21 |
| AU2006281300A1 (en) | 2007-02-22 |
| ECSP088250A (es) | 2008-04-28 |
| KR20080039939A (ko) | 2008-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200531689A (en) | Therapeutic agents | |
| TW200504034A (en) | Therapeutic agents | |
| TW200635903A (en) | Therapeutic agents | |
| TW200801029A (en) | Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture | |
| TW200730525A (en) | Therapeutic agents | |
| MY179527A (en) | Catecholamine derivatives useful for the treatment of parkinson's disease | |
| UA92503C2 (ru) | Соединения 5-(фенилизоксазолилэтокси)-триазол-3-ил-замещенного пиридина для лечения неврологических, психиатрических или болевых расстройств | |
| IL196543A (en) | Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders | |
| GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
| TW200635599A (en) | Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture | |
| MXPA05013711A (es) | Derivados 3-sustituidos de 5,6-diaril-pirazin-2-carboxi-amida y -2-sulfonamida, como moduladores de cb1. | |
| WO2007038209A3 (en) | Fused tetracyclic mglur1 antagonists as therapeutic agents | |
| TW200633986A (en) | Therapeutic agents | |
| MXPA05010712A (es) | Derivados de quinolin-2-ona para el tratamiento de enfermedades de las vias respiratorias. | |
| PL1951729T3 (pl) | Pochodne pirymidyny połączone przez atom tlenu | |
| JO2686B1 (en) | Vehicles | |
| TW200509933A (en) | Therapeutic agents | |
| MX2009004745A (es) | Derivados de 1,2,3-triazol como inhibidores del receptor sigma. | |
| TW200505904A (en) | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands | |
| IL188942A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing the same | |
| TW200745135A (en) | Therapeutic agents | |
| NO20080372L (no) | Pyrazolderivater som teraputiske midler | |
| ECSP088366A (es) | 1,2-diarilimidazoles para uso como moduladores de cb1 | |
| IL191751A0 (en) | Pyrrolo[2,3-c]pyridine derivatives | |
| TW200630374A (en) | Thiazolyldihydroindazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |